| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.008 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.16 | 0.5 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.003 |